20% off first-time orders with code FREEDOM. Military, Veterans and First Responders: explore our Heroes Program.

Quality Peptide USAQuality Peptide USA
HomeResearchCJC-1295 (No DAC)
Mechanism of Action

CJC-1295 (No DAC) Mechanism of Action: Receptor & Signaling Profile

3 min read•Published 2025-08-08•Quality Peptide USA Research

CJC-1295 (No DAC) — also known as Modified GRF 1-29 — is a 29-amino-acid analog of growth hormone–releasing hormone (GHRH) lacking the Drug Affinity Complex. Without albumin binding, it retains a short, physiologically pulsatile profile in research models. This guide covers mechanism of action for CJC-1295 (No DAC) — written for laboratory researchers sourcing US-synthesized peptides from Quality Peptide USA.

Primary Receptor Engagement

Activates the GHRH receptor on pituitary somatotrophs, stimulating pulsatile GH release in laboratory models without the prolonged baseline elevation produced by DAC-conjugated analogs.

Downstream Signaling Cascades

Activation triggers second-messenger cascades that have been mapped in cell-line and primary-tissue models. Researchers studying CJC-1295 (No DAC) commonly track cAMP accumulation, MAPK phosphorylation, or PI3K/Akt activation as functional readouts. In pulsatile gh-axis research, these cascades correlate with the phenotypic endpoints most often reported in peer-reviewed studies.

Selectivity and Off-Target Profile

Selectivity is one of the most important variables when designing experiments around CJC-1295 (No DAC). Off-target activity at related receptor families is generally minimal in standard binding panels, but investigators using high-concentration protocols should validate selectivity in their specific cell line. For research comparing CJC-1295 (No DAC) to structurally adjacent peptides, side-by-side dose-response curves remain the gold standard.

Why Mechanism Drives Sourcing

Subtle sequence impurities can mask or amplify mechanism-driven readouts. That is why every batch of CJC-1295 (No DAC) sold by Quality Peptide USA is verified by HPLC-MS for sequence integrity, with mass spectrometry traces included in the published certificate of analysis. US-synthesized peptides give research teams confidence that observed mechanism effects reflect the molecule — not a contaminant.

Research Use Only

All content is for laboratory and in-vitro research contexts only. Not intended to diagnose, treat, or prevent any condition. Not for human or veterinary consumption.

CJC-1295 (No DAC)CJC-1295 (No DAC) researchCJC-1295 (No DAC) mechanism of actionCJC-1295 (No DAC) for salebuy CJC-1295 (No DAC)CJC-1295 (No DAC) US synthesizedCJC-1295 (No DAC) American peptidesCJC-1295 (No DAC) certificate of analysisresearch peptidesQuality Peptide USA